Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Awards under Value Creation Plan

13 Jul 2012 07:00

RNS Number : 5816H
BrainJuicer Group PLC
13 July 2012
Β 

Β 

Β 

Β 

Press Release

13 July 2012

Β 

BrainJuicer Group PLC (AIM:BJU)

Β ("BrainJuicer" and the "Company")

Β 

Β 

Awards under the Company's 2010 Value Creation Plan

Β 

Β 

BrainJuicer, a leading international online market research agency, announces that on 12 July 2012, it awarded the remaining unused units in its 2010 Value Creation Plan ("VCP"), in the main, to existing participants in the plan. These awards included the following awards to Directors of the Company.

Β 

Director

VCP units prior to the award date

VCP units awarded on 12 July 2012

VCP units immediately following the award date

John Kearon

1,235

265

1,500

Alex Batchelor

1,235

265

1,500

James Geddes

1,235

265

1,500

Β 

The VCP plan was introduced in 2010 and matures in 2014. Details can be found in the Notice of 2010 Annual General Meeting on the Company's website (www.brainjuicer.com), and are summarised below.

Β 

VCP units will provide remuneration for participants if the Company's "Achieved Share Price" (being the average closing price of a share over the 30 day period ending 30 April 2014) exceeds Β£3.00 per share. The total VCP remuneration for all participants will be equal to 15% of any increase in the Company's share value between Β£3.00 per share and the Achieved Share Price. This value will be allocated to participants in proportion to their units by way of share awards.

Β 

In the event that the Achieved Share Price is less than Β£3.00, the VCP units shall not be converted into share awards and will lapse.

Β 

Following the awards on 12 July 2012, each Director's share of the total VCP value is 15%.

Β 

Β 

Β 

- Ends -

Β 

Β 

Β 

For further information, please contact:

BrainJuicer Group PLC

John Kearon, Chief Executive Officer

Tel: +44 (0)20 7043 1000

James Geddes, Chief Financial Officer

www.brainjuicer.com

Β 

Canaccord Genuity Limited

Simon Bridges / Henry Fitzgerald-O'Connor

Tel: +44 (0)20 7523 8000

www.canaccordgenuity.com

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCEAKXAFDPAEFF
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.